Epimedium sagittatum
Epimedium sagittatum
Epimedium sagittatum, commonly known as Horny Goat Weed, originates from traditional Chinese medicine and is associated with various folk remedies. While its specific uses are not well-documented in traditional practices, scientific studies have shown potential benefits. Research indicates that exosome-like nanovesicles derived from Epimedium may help alleviate sepsis-associated acute kidney injury by targeting the gut-kidney axis. Additionally, Ica Ⅱ from this plant improved lung function and reduced fibrosis markers in mice with pulmonary fibrosis through modulation of E-cadherin-related pathways. Three compounds identified from Epimedium sagittatum demonstrated significant inhibition of PDE5A, suggesting potential for therapeutic applications. No major safety concerns or known drug interactions have been recorded to date.
- Best evidence
- D
- Cautions
- —
Informational only. Traditional use does not mean proven effectiveness. Evidence and safety vary — check the cited sources.
What the science says
- Epimedium-derived exosome-like nanovesicles showed potential in alleviating sepsis-associated acute kidney injury by targeting the gut-kidney axis.
- The study reveals diverse mitochondrial genome structures, RNA editing patterns, and phylogenetic relationships among three Epimedium species.
- Ica Ⅱ from Epimedium sagittatum improved lung function and reduced fibrosis markers in mice with pulmonary fibrosis by modulating E-cadherin-related pathways.
- This study identified three compounds from Epimedium sagittatum that show significant inhibition of PDE5A.
Frequently asked questions
What is Epimedium sagittatum?
Epimedium sagittatum (Epimedium sagittatum) is a plant documented in FolkKB's traditional-medicine reference, drawn from sourced literature and cross-checked against the evidence.
What does the scientific evidence say about Epimedium sagittatum?
4 sourced findings are recorded for Epimedium sagittatum; the strongest carries evidence grade D. For example: Epimedium-derived exosome-like nanovesicles showed potential in alleviating sepsis-associated acute kidney injury by targeting the gut-kidney axis.
How strong is the evidence for Epimedium sagittatum?
The strongest finding for Epimedium sagittatum carries evidence grade D — preliminary or traditional. Grades run A (strongest) to D (preliminary or traditional).
Is Epimedium sagittatum safe? What are the side effects?
No major safety issues are recorded for Epimedium sagittatum in our sources, but the data may be incomplete. Consult a qualified professional before use.
Does Epimedium sagittatum interact with medications?
No drug interactions are recorded for Epimedium sagittatum in our sources. This does not rule them out — check with a pharmacist.
Is Epimedium sagittatum a proven treatment?
No. FolkKB is informational only. Traditional use and early findings are not proof of efficacy or safety — consult a qualified professional and never self-treat.
Sources
- T2 2″-O-rhamnosyl icariside Ⅱ from Epimedium sagittatum maxim ameliorates pulmonary fibrosis by modulating the E-cadherin-mediated oxidative-epithelial mesenchymal transition axis. literature abstract metadata
- T2 Comparative analysis of mitochondrial genomes of Epimedium L. reveals heterogeneity in structure, synteny, intercellular gene transfer, and RNA editing. literature abstract metadata
- T2 Mechanistic study of PDE5A inhibitors from the prepared folium of Epimedium sagittatum maxim. literature abstract metadata
- T2 Epimedium-Derived Exosome-like Nanovesicles Regulate Lipid Metabolism via the "Gut-Kidney Axis" for Multitargeted Inhibition of Sepsis-Associated Acute Kidney Injury. literature abstract metadata